Carta / editorial Nutrição e metabolismo

GLP-1 and Dual GLP-1/GIP Receptor Agonists in Lipedema: A Promising Therapeutic Option Requiring Rigorous Evaluation

Litaiem N, Slouma M
International journal of dermatology · 7 out 2026 · DOI 10.1111/ijd.70720 · PMID 42839854

Abstract original

Este registro não tem abstract no PubMed. Consulte o artigo completo pelo link abaixo.

glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs)glucose‐dependent insulinotropic polypeptide (GIP)inflammation insulin resistance lipedema obesity

Mais em Nutrição e metabolismo

Relato de caso Nutrição

Lipedema in a male patient: familial evidence and clinical response to nutritional intervention - case report

Lipedema is a chronic adipose tissue disorder that predominantly affects women, although some rare cases do occur in men. We report the case of a 32-year-old man with symmetrical, lower-limb fat accumulation, foot sparing, pain,…

Kaefer M et al. · Jornal vascular brasileiro · 9 out 2026

Revisão Nutrição

Lipoedema and Obesity Misclassification: A Phenotype Based Approach to Cardiometabolic Risk Beyond Body Mass Index

Lipoedema is a painful adipose tissue disorder marked by disproportionate limb fat and often misclassified as generalized obesity or lymphoedema. This review examines its metabolic phenotype and implications for cardiometabolic…

Varghese RT, Varghese DG · Clinical obesity · 1 out 2026

Estudo original Nutrição

Body Composition Changes With Standard Versus Low-Dose Tirzepatide Titration in Women With Lipedema: A Retrospective Observational Study

This study aimed to compare 12-week changes in body composition and anthropometric parameters between standard-dose and lower-dose tirzepatide escalation regimens in women with lipedema, with particular emphasis on changes in fat…

Frederichi de Souza P, Patriani G, Ribeiro Pacheco CM · Cureus · 23 set 2026